28%
of UK central government technology is classed as legacy, up from 26% a year earlier.
Investors
Retailers, manufacturers, hospitals, government departments and banks still run on software written decades ago, and replacing it is risky: when TSB’s 2018 switch to a new platform failed on the day, it ended in a £48.65 million fine. Our flagship product, Sovereign, rebuilds these systems in modern code and proves the new one gives the same results before anyone switches over.
The problem
Everyone who owns these systems knows they must replace them. Few dare, because a failed switch lands on customers, regulators and the front page.
of UK central government technology is classed as legacy, up from 26% a year earlier.
what it costs to maintain a legacy system compared with a modern one, as HMRC’s contracts for its COBOL systems show.
in fines after TSB’s 2018 switch to a new banking platform failed on the day.
Sources: UK Government, State of digital government review (January 2025); FCA and Bank of England (2022).
Why Syntaxe
You want evidence, not promises. Every claim we make comes with evidence you can check.
Proven on real code
Sovereign rebuilds and proves COBOL, PL/I, JCL, Fortran, MUMPS, REXX, Perl and ColdFusion, each checked against its own compiler or interpreter.
Built for the hardest buyers
It installs on the customer’s own machines and needs no internet connection, so government, defence and regulated industries can use it.
Checkable
Every result comes with the inputs, both outputs and the source lines behind it, so the customer’s team can check it without us.
Recognised
Syntaxe is part of NVIDIA Inception, NVIDIA’s programme for AI companies.
What we have built
Sovereign is our flagship. The same team builds three more products, in cybersecurity and scientific research.
How to invest
Tell us about your fund and the stage you invest at.
We send the deck, the product evidence and our plan.
Ask us anything by email. You decide with the full picture.
What you are backing
We reply with the deck, the product evidence and answers to your questions.